PKU HealthCare Corp.,Ltd. (SHE:000788)

Market Cap	3.41B -5.0%
Revenue (ttm)	1.76B -15.2%
Net Income	143.61M +11.7%
EPS	0.24 +11.7%
Shares Out	595.99M
PE Ratio	23.74
Forward PE	n/a
Dividend	0.20 (3.36%)
Ex-Dividend Date	Mar 10, 2026

Volume	11,886,100
Average Volume	11,701,903
Open	5.94
Previous Close	5.90
Day's Range	5.71 - 5.95
52-Week Range	4.91 - 7.99
Beta	0.21
RSI	35.32
Earnings Date	Apr 28, 2026

About PKU HealthCare Corp.,Ltd.

PKU HealthCare Corp.,Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers products in various categories, including cardiovascular and cerebrovascular, antimicrobial, antipyretic and analgesic, digestive system, oncology, anti-allergic, blood sugar and immunity regulation, mental disorder, and blood volume expansion. It also provides tumor screening, health management, diagnosis, and treatment services. The compa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 772
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000788

Financial Performance

In 2024, PKU HealthCare Corp.,Ltd.'s revenue was 2.06 billion, a decrease of -6.10% compared to the previous year's 2.19 billion. Earnings were 137.99 million, an increase of 211.10%.